Back to Journals » Drug Design, Development and Therapy » Volume 14

HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial–Mesenchymal Transition

Total article views   HTML views PDF downloads Totals
6,047 Dovepress* 5,665+ 742 6,407
PubMed Central* 382 129 511
Totals 6,047 871 6,918
*Since 15 October 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed and Google Scholar